Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

502 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Triple-negative breast cancer.
Foulkes WD, Smith IE, Reis-Filho JS. Foulkes WD, et al. Among authors: smith ie. N Engl J Med. 2010 Nov 11;363(20):1938-48. doi: 10.1056/NEJMra1001389. N Engl J Med. 2010. PMID: 21067385 Review.
Towards a molecular basis for tamoxifen resistance in breast cancer.
Johnston SR, Dowsett M, Smith IE. Johnston SR, et al. Among authors: smith ie. Ann Oncol. 1992 Jul;3(7):503-11. doi: 10.1093/oxfordjournals.annonc.a058251. Ann Oncol. 1992. PMID: 1498070 Review.
Changes in estrogen receptor, progesterone receptor, and pS2 expression in tamoxifen-resistant human breast cancer.
Johnston SR, Saccani-Jotti G, Smith IE, Salter J, Newby J, Coppen M, Ebbs SR, Dowsett M. Johnston SR, et al. Among authors: smith ie. Cancer Res. 1995 Aug 1;55(15):3331-8. Cancer Res. 1995. PMID: 7614468
ABC of breast diseases. Role of systemic treatment for primary operable breast cancer.
Richards MA, Smith IE, Dixon JM. Richards MA, et al. Among authors: smith ie. BMJ. 1994 Nov 19;309(6965):1363-6. doi: 10.1136/bmj.309.6965.1363. BMJ. 1994. PMID: 7866090 Free PMC article. Review. No abstract available.
Acquired tamoxifen resistance in human breast cancer and reduced intra-tumoral drug concentration.
Johnston SR, Haynes BP, Smith IE, Jarman M, Sacks NP, Ebbs SR, Dowsett M. Johnston SR, et al. Among authors: smith ie. Lancet. 1993 Dec 18-25;342(8886-8887):1521-2. doi: 10.1016/s0140-6736(05)80088-1. Lancet. 1993. PMID: 7902904
Response to third-line endocrine treatment for advanced breast cancer.
Iveson TJ, Ahern J, Smith IE. Iveson TJ, et al. Among authors: smith ie. Eur J Cancer. 1993;29A(4):572-4. doi: 10.1016/s0959-8049(05)80154-6. Eur J Cancer. 1993. PMID: 8435212
The prognostic implications of chemotherapy in the treatment of breast cancer.
O'Brien ME, Smith IE. O'Brien ME, et al. Among authors: smith ie. Curr Opin Obstet Gynecol. 1996 Feb;8(1):21-6. Curr Opin Obstet Gynecol. 1996. PMID: 8777253 Review.
Primary chemotherapy for early breast cancer.
Ellis PA, Smith IE. Ellis PA, et al. Among authors: smith ie. Cancer Treat Rev. 1996 Nov;22(6):437-50. doi: 10.1016/s0305-7372(96)90025-0. Cancer Treat Rev. 1996. PMID: 9134004 Review.
Induction of apoptosis by tamoxifen and ICI 182780 in primary breast cancer.
Ellis PA, Saccani-Jotti G, Clarke R, Johnston SR, Anderson E, Howell A, A'Hern R, Salter J, Detre S, Nicholson R, Robertson J, Smith IE, Dowsett M. Ellis PA, et al. Among authors: smith ie. Int J Cancer. 1997 Aug 7;72(4):608-13. doi: 10.1002/(sici)1097-0215(19970807)72:4<608::aid-ijc10>3.0.co;2-7. Int J Cancer. 1997. PMID: 9259399 Clinical Trial.
Primary chemotherapy in breast cancer.
Smith IE, al-Moundhri M. Smith IE, et al. Biomed Pharmacother. 1998;52(3):116-21. doi: 10.1016/S0753-3322(98)80089-9. Biomed Pharmacother. 1998. PMID: 9755804 Review.
502 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback